research Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia
This review discusses the use of 5α-reductase inhibitors in treating benign prostatic hyperplasia, highlighting their long-term effectiveness and benefits when combined with α1-adrenergic antagonists; it reports no new clinical results.